Johnson & Johnson Land
Johnson & Johnson (JNJ) had Land of $882.00 million as of 2021-01-03, per its 10-K filed 2021-02-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:Land · last filed 2021-02-22
- 2021-01-03: Land $882.00M.
- 2019-12-29: Land $854.00M.
- 2018-12-30: Land $807.00M.
- 2017-12-31: Land $829.00M.
| Period end | Land |
|---|---|
| 2021-01-03 | $882.00M 10-K · filed 2021-02-22 |
| 2019-12-29 | $854.00M 10-K · filed 2021-02-22 |
| 2018-12-30 | $807.00M 10-K · filed 2020-02-18 |
| 2017-12-31 | $829.00M 10-K · filed 2019-02-20 |
| 2017-01-01 | $753.00M 10-K · filed 2018-02-21 |
| 2016-01-03 | $780.00M 10-K · filed 2017-02-27 |
| 2014-12-28 | $833.00M 10-K · filed 2016-02-24 |
| 2013-12-29 | $885.00M 10-K · filed 2015-02-24 |
| 2012-12-30 | $793.00M 10-K · filed 2014-02-21 |
| 2012-01-01 | $754.00M 10-K · filed 2013-02-22 |
| 2011-01-02 | $738.00M 10-K · filed 2012-02-23 |
| 2010-01-03 | $714.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |